Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Perceived stress and smoking-related behaviors and symptomatology in male and female smokers.

Lawless MH, Harrison KA, Grandits GA, Eberly LE, Allen SS.

Addict Behav. 2015 Dec;51:80-3. doi: 10.1016/j.addbeh.2015.07.011. Epub 2015 Jul 26.

2.

Quality of life assessment among HIV-positive persons entering the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.

Lifson AR, Grandits GA, Gardner EM, Wolff MJ, Pulik P, Williams I, Burman WJ; International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) START Study Group.

HIV Med. 2015 Apr;16 Suppl 1:88-96. doi: 10.1111/hiv.12237.

3.
4.

Effect of carvedilol, lisinopril and their combination on vascular and cardiac health in patients with borderline blood pressure: the DETECT Study.

Saul SM, Duprez DA, Zhong W, Grandits GA, Cohn JN.

J Hum Hypertens. 2013 Jun;27(6):362-7. doi: 10.1038/jhh.2012.54. Epub 2012 Nov 29.

PMID:
23190794
5.

Chlorhexidine does not select for resistance in Staphylococcus aureus isolates in a community setting.

Johnson MD, Schlett CD, Grandits GA, Mende K, Whitman TJ, Tribble DR, Hospenthal DR, Murray PR.

Infect Control Hosp Epidemiol. 2012 Oct;33(10):1061-3. doi: 10.1086/667744. No abstract available.

PMID:
22961032
6.

The impact of enzyme-inducing antiepileptic drugs on antiretroviral drug levels: a case-control study.

Okulicz JF, Grandits GA, French JA, Perucca E, George JM, Landrum ML, Acosta EP, Birbeck GL.

Epilepsy Res. 2013 Feb;103(2-3):245-53. doi: 10.1016/j.eplepsyres.2012.07.009. Epub 2012 Jul 24.

7.

Chlorhexidine gluconate reduces transmission of methicillin-resistant Staphylococcus aureus USA300 among Marine recruits.

Whitman TJ, Schlett CD, Grandits GA, Millar EV, Mende K, Hospenthal DR, Murray PR, Tribble DR.

Infect Control Hosp Epidemiol. 2012 Aug;33(8):809-16. doi: 10.1086/666631. Epub 2012 Jun 11.

8.

Spontaneous virologic suppression in HIV controllers is independent of delayed-type hypersensitivity test responsiveness.

Okulicz JF, Grandits GA, Dolan MJ, Marconi VC, Wortmann G, Landrum ML.

AIDS Res Ther. 2012 Apr 2;9:10. doi: 10.1186/1742-6405-9-10.

9.

Vascular and cardiac functional and structural screening to identify risk of future morbid events: preliminary observations.

Duprez DA, Florea N, Zhong W, Grandits GA, Hawthorne CK, Hoke L, Cohn JN.

J Am Soc Hypertens. 2011 Sep-Oct;5(5):401-9. doi: 10.1016/j.jash.2011.05.001. Epub 2011 Jun 29.

PMID:
21719371
10.

Virologic outcomes of HAART with concurrent use of cytochrome P450 enzyme-inducing antiepileptics: a retrospective case control study.

Okulicz JF, Grandits GA, French JA, George JM, Simpson DM, Birbeck GL, Ganesan A, Weintrob AC, Crum-Cianflone N, Lalani T, Landrum ML; Infectious Disease Clinical Research Program (IDCRP) HIV Working Group.

AIDS Res Ther. 2011 May 16;8:18. doi: 10.1186/1742-6405-8-18.

11.

Long-term safety and serologic response to measles, mumps, and rubella vaccination in HIV-1 infected adults.

Stermole BM, Grandits GA, Roediger MP, Clark BM, Ganesan A, Weintrob AC, Crum-Cianflone NF, Ferguson TM, Macalino GE, Landrum ML.

Vaccine. 2011 Apr 5;29(16):2874-80. doi: 10.1016/j.vaccine.2011.02.013. Epub 2011 Feb 23.

12.

Chlorhexidine-impregnated cloths to prevent skin and soft-tissue infection in Marine recruits: a cluster-randomized, double-blind, controlled effectiveness trial.

Whitman TJ, Herlihy RK, Schlett CD, Murray PR, Grandits GA, Ganesan A, Brown M, Mancuso JD, Adams WB, Tribble DR.

Infect Control Hosp Epidemiol. 2010 Dec;31(12):1207-15. doi: 10.1086/657136. Epub 2010 Oct 28.

PMID:
21028984
13.

Outcomes of highly active antiretroviral therapy in the context of universal access to healthcare: the U.S. Military HIV Natural History Study.

Marconi VC, Grandits GA, Weintrob AC, Chun H, Landrum ML, Ganesan A, Okulicz JF, Crum-Cianflone N, O'Connell RJ, Lifson A, Wortmann GW, Agan BK; Infectious Disease Clinical Research Program HIV Working Group (IDCRP).

AIDS Res Ther. 2010 May 27;7:14. doi: 10.1186/1742-6405-7-14.

14.

CD4 T cell count reconstitution in HIV controllers after highly active antiretroviral therapy.

Okulicz JF, Grandits GA, Weintrob AC, Landrum ML, Ganesan A, Crum-Cianflone NF, Agan BK, Marconi VC.

Clin Infect Dis. 2010 Apr 15;50(8):1187-91. doi: 10.1086/651421.

PMID:
20218878
15.

Virologic response differences between African Americans and European Americans initiating highly active antiretroviral therapy with equal access to care.

Weintrob AC, Grandits GA, Agan BK, Ganesan A, Landrum ML, Crum-Cianflone NF, Johnson EN, Ordóñez CE, Wortmann GW, Marconi VC; IDCRP HIV Working Group.

J Acquir Immune Defic Syndr. 2009 Dec;52(5):574-80. doi: 10.1097/QAI.0b013e3181b98537.

PMID:
19755913
16.

Relation of heart rate parameters during exercise test to sudden death and all-cause mortality in asymptomatic men.

Adabag AS, Grandits GA, Prineas RJ, Crow RS, Bloomfield HE, Neaton JD; MRFIT Research Group.

Am J Cardiol. 2008 May 15;101(10):1437-43. doi: 10.1016/j.amjcard.2008.01.021. Epub 2008 Mar 19.

17.
18.

Arterial elasticity as part of a comprehensive assessment of cardiovascular risk and drug treatment.

Cohn JN, Duprez DA, Grandits GA.

Hypertension. 2005 Jul;46(1):217-20. Epub 2005 May 2. Review.

PMID:
15867132
19.

Obtaining event status at the close of the Treatment of Mild Hypertension Study: methods and implication for other trials.

Grandits GA, Grimm RH Jr, Prineas RJ, Grambsch P, Holland LA.

Control Clin Trials. 2001 Feb;22(1):56-61.

PMID:
11165424
20.

Urinary isoflavonoid and lignan excretion on a Western diet: relation to soy, vegetable, and fruit intake.

Lampe JW, Gustafson DR, Hutchins AM, Martini MC, Li S, Wähälä K, Grandits GA, Potter JD, Slavin JL.

Cancer Epidemiol Biomarkers Prev. 1999 Aug;8(8):699-707.

21.

Effect of calcium supplementation on serum cholesterol and blood pressure. A randomized, double-blind, placebo-controlled, clinical trial.

Bostick RM, Fosdick L, Grandits GA, Grambsch P, Gross M, Louis TA.

Arch Fam Med. 2000 Jan;9(1):31-8; discussion 39.

PMID:
10664640
22.
23.

Colorectal epithelial cell proliferative kinetics and risk factors for colon cancer in sporadic adenoma patients.

Bostick RM, Fosdick L, Grandits GA, Lillemoe TJ, Wood JR, Grambsch P, Louis TA, Potter JD.

Cancer Epidemiol Biomarkers Prev. 1997 Dec;6(12):1011-9.

24.

Higher education and income are related to a better Na:K ratio in blacks: baseline results of the Treatment of Mild Hypertension Study (TOMHS) data.

Ganguli MC, Grimm RH Jr, Svendsen KH, Flack JM, Grandits GA, Elmer PJ.

Am J Hypertens. 1997 Sep;10(9 Pt 1):979-84.

PMID:
9324102
25.

Relationships of quality-of-life measures to long-term lifestyle and drug treatment in the Treatment of Mild Hypertension Study.

Grimm RH Jr, Grandits GA, Cutler JA, Stewart AL, McDonald RH, Svendsen K, Prineas RJ, Liebson PR.

Arch Intern Med. 1997 Mar 24;157(6):638-48.

PMID:
9080918
26.

Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hypertension Study (TOMHS)

Grimm RH Jr, Grandits GA, Prineas RJ, McDonald RH, Lewis CE, Flack JM, Yunis C, Svendsen K, Liebson PR, Elmer PJ.

Hypertension. 1997 Jan;29(1 Pt 1):8-14.

PMID:
9039073
27.

Relation of smoking at baseline and during trial years 1-6 to food and nutrient intakes and weight in the special intervention and usual care groups in the Multiple Risk Factor Intervention Trial.

Stamler J, Rains-Clearman D, Lenz-Litzow K, Tillotson JL, Grandits GA.

Am J Clin Nutr. 1997 Jan;65(1 Suppl):374S-402S. doi: 10.1093/ajcn/65.1.374S.

PMID:
8988949
28.
29.

Relation of dietary fiber to blood lipids in the special intervention and usual care groups in the Multiple Risk Factor Intervention Trial.

Tillotson JL, Grandits GA, Bartsch GE, Stamler J.

Am J Clin Nutr. 1997 Jan;65(1 Suppl):327S-337S. doi: 10.1093/ajcn/65.1.327S.

PMID:
8988946
30.

Relation of dietary carbohydrates to blood lipids in the special intervention and usual care groups in the Multiple Risk Factor Intervention Trial.

Tillotson JL, Grandits GA, Bartsch GE, Stamler J.

Am J Clin Nutr. 1997 Jan;65(1 Suppl):314S-326S. doi: 10.1093/ajcn/65.1.314S.

PMID:
8988945
31.

Nutritional adequacy of diets reported at baseline and during trial years 1-6 by the special intervention and usual care groups in the Multiple Risk Factor Intervention Trial.

Dolecek TA, Johnson RL, Grandits GA, Farrand-Zukel M, Caggiula AW.

Am J Clin Nutr. 1997 Jan;65(1 Suppl):305S-313S. doi: 10.1093/ajcn/65.1.305S.

PMID:
8988944
32.

Adherence to dietary recommendations in the special intervention group in the Multiple Risk Factor Intervention Trial.

Van Horn L, Dolecek TA, Grandits GA, Skweres L.

Am J Clin Nutr. 1997 Jan;65(1 Suppl):289S-304S. doi: 10.1093/ajcn/65.1.289S.

PMID:
8988943
33.

Relation of changes in dietary lipids and weight, trial years 1-6, to changes in blood lipids in the special intervention and usual care groups in the Multiple Risk Factor Intervention Trial.

Stamler J, Briefel RR, Milas C, Grandits GA, Caggiula AW.

Am J Clin Nutr. 1997 Jan;65(1 Suppl):272S-288S. doi: 10.1093/ajcn/65.1.272S.

PMID:
8988942
34.

Food group and macronutrient intakes, trial years 1-6, in the special intervention and usual care groups in the Multiple Risk Factor Intervention Trial.

Gorder DD, Bartsch GE, Tillotson JL, Grandits GA, Stamler J.

Am J Clin Nutr. 1997 Jan;65(1 Suppl):258S-271S. doi: 10.1093/ajcn/65.1.258S.

PMID:
8988941
35.

Food group and nutrient intakes at baseline in the Multiple Risk Factor Intervention Trial.

Tillotson JL, Bartsch GE, Gorder D, Grandits GA, Stamler J.

Am J Clin Nutr. 1997 Jan;65(1 Suppl):228S-257S. doi: 10.1093/ajcn/65.1.228S.

PMID:
8988940
36.

Method issues in dietary data analyses in the Multiple Risk Factor Intervention Trial.

Grandits GA, Bartsch GE, Stamler J.

Am J Clin Nutr. 1997 Jan;65(1 Suppl):211S-227S. doi: 10.1093/ajcn/65.1.211S.

PMID:
8988939
37.

Relationship to blood pressure of combinations of dietary macronutrients. Findings of the Multiple Risk Factor Intervention Trial (MRFIT).

Stamler J, Caggiula A, Grandits GA, Kjelsberg M, Cutler JA.

Circulation. 1996 Nov 15;94(10):2417-23.

PMID:
8921782
38.

Hormone replacement therapy is associated with lower risk of adenomatous polyps of the large bowel: the Minnesota Cancer Prevention Research Unit Case-Control Study.

Potter JD, Bostick RM, Grandits GA, Fosdick L, Elmer P, Wood J, Grambsch P, Louis TA.

Cancer Epidemiol Biomarkers Prev. 1996 Oct;5(10):779-84.

39.

Long-term effects on plasma lipids of diet and drugs to treat hypertension. Treatment of Mild Hypertension Study (TOMHS) Research Group.

Grimm RH Jr, Flack JM, Grandits GA, Elmer PJ, Neaton JD, Cutler JA, Lewis C, McDonald R, Schoenberger J, Stamler J.

JAMA. 1996 May 22-29;275(20):1549-56.

PMID:
8622245
40.

Calcium and colorectal epithelial cell proliferation in sporadic adenoma patients: a randomized, double-blinded, placebo-controlled clinical trial.

Bostick RM, Fosdick L, Wood JR, Grambsch P, Grandits GA, Lillemoe TJ, Louis TA, Potter JD.

J Natl Cancer Inst. 1995 Sep 6;87(17):1307-15.

PMID:
7658483
41.

Plasma carotenoids as biomarkers of vegetable intake: the University of Minnesota Cancer Prevention Research Unit Feeding Studies.

Martini MC, Campbell DR, Gross MD, Grandits GA, Potter JD, Slavin JL.

Cancer Epidemiol Biomarkers Prev. 1995 Jul-Aug;4(5):491-6.

42.
43.

Urinary albumin and N-acetyl-beta-D-glucosaminidase excretions in mild hypertension.

Abraham PA, Mascioli SR, Launer CA, Flack JM, Liebson PR, Svendsen KH, Grandits GA, Opsahl JA, Schoenberger JA, Grimm RH Jr.

Am J Hypertens. 1994 Nov;7(11):965-74.

PMID:
7848623
44.

Echocardiography in multicenter clinical trials: experience from the Treatment of Mild Hypertension Study.

Grandits GA, Liebson PR, Dianzumba S, Prineas RJ.

Control Clin Trials. 1994 Oct;15(5):395-410.

PMID:
8001359
45.

Plasma carotenoids as biomarkers of vegetable and fruit intake.

Campbell DR, Gross MD, Martini MC, Grandits GA, Slavin JL, Potter JD.

Cancer Epidemiol Biomarkers Prev. 1994 Sep;3(6):493-500.

46.

Statistical analysis of proliferative index data in clinical trials.

Grambsch P, Louis TA, Bostick RM, Grandits GA, Fosdick L, Darif M, Potter JD.

Stat Med. 1994 Aug 30;13(16):1619-34.

PMID:
7973238
47.

Insulin as a predictor of coronary heart disease: interaction with apolipoprotein E phenotype. A report from the Multiple Risk Factor Intervention Trial.

Orchard TJ, Eichner J, Kuller LH, Becker DJ, McCallum LM, Grandits GA.

Ann Epidemiol. 1994 Jan;4(1):40-5.

PMID:
8205270
48.

Treatment of Mild Hypertension Study. Final results. Treatment of Mild Hypertension Study Research Group.

Neaton JD, Grimm RH Jr, Prineas RJ, Stamler J, Grandits GA, Elmer PJ, Cutler JA, Flack JM, Schoenberger JA, McDonald R, et al.

JAMA. 1993 Aug 11;270(6):713-24.

PMID:
8336373
49.

Relation of apolipoprotein E phenotype to myocardial infarction and mortality from coronary artery disease.

Eichner JE, Kuller LH, Orchard TJ, Grandits GA, McCallum LM, Ferrell RE, Neaton JD.

Am J Cardiol. 1993 Jan 15;71(2):160-5.

PMID:
8421977
50.

The relation between serum albumin levels and risk of coronary heart disease in the Multiple Risk Factor Intervention Trial.

Kuller LH, Eichner JE, Orchard TJ, Grandits GA, McCallum L, Tracy RP.

Am J Epidemiol. 1991 Dec 1;134(11):1266-77.

PMID:
1755441

Supplemental Content

Loading ...
Support Center